Unichem, Pliva agree to market generics in United States

By Lisa Kerner

Erie, Pa., May 19 - Unichem Laboratories Ltd. has entered into a product development, manufacturing and supply agreement with Pliva Inc. USA, a wholly owned subsidiary of Pliva Pharmaceuticals, Zagreb, Croatia, initially covering five products in advanced development, according to a news release.

Pliva will fund certain development in exchange for exclusive marketing rights to generic products under joint label in U.S. markets.

Unichem plans to enter into similar marketing agreements for its generic products and is considering possible acquisitions in the United States, officials said.

Unichem is a Mumbai, India-based pharmaceutical company.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.